Dr. Lustberg is an Assoc Prof of Internal Medicine, OSU, Div of Med Onc. She is Chair of Multinational Association of Supportive Care in Cancer (MASCC) Neurological Complications Committee and is the next President Elect. The goal of her research is to identify predictive biomarkers to prevent/lessen treatment-related toxicity and personalize cancer treatments. As an oncologist working with patients with Her2 + breast cancer, she will work closely with the team to ensure successful effort execution. She completed a Medical Oncology fellowship and a Breast Cancer fellowship at The Ohio State University Comprehensive Cancer Center (OSUCCC). During this time, she completed a MPH degree in clinical investigation with a focus in clinical translational research in breast cancer. In August 2010, she joined faculty as Assistant Professor in the division of Medical Oncology. She is the Director of Breast Cancer Survivorship in the Stefanie Spielman Comprehensive Breast Center and Medical Director of the Supportive Care Program of The James-OSUCCC. Her research focuses on identifying novel genomic predictors as well as blood and imaging biomarkers for treatment toxicity and survivorship management. She is currently a member of the ASCO Neuropathy Task Force, the Alliance Symptom Management Committee and the Alliance Neuropathy Interest Group, and the Chair of the Multinational Association of Supportive Care in Cancer (MASCC) Neurological Complications Committee. With these efforts, the goal of her research is to identify predictive biomarkers to prevent or lessen treatment-related toxicity and ultimately personalize cancer treatments. She also directs the Adolescent and Young Adult Program at the OSUCCC.